Reference
1. Bearpark L, Sartipy U, Franco-Cereceda A, Glaser N. Surgery for
Endocarditis in Intravenous Drug Users. Ann Thorac Surg .
2021;112(2):573-581. doi:10.1016/j.athoracsur.2020.09.013
2. Nguemeni Tiako MJ, Mori M, Bin Mahmood SU, et al. Recidivism Is the
Leading Cause of Death Among Intravenous Drug Users Who Underwent
Cardiac Surgery for Infective Endocarditis. Semin Thorac
Cardiovasc Surg . 2019;31(1):40-45. doi:10.1053/j.semtcvs.2018.07.016
3. Shmueli H, Thomas F, Flint N, Setia G, Janjic A, Siegel RJ.
RightâSided Infective Endocarditis 2020: Challenges and Updates in
Diagnosis and Treatment. J Am Heart Assoc . 2020;9(15):e017293.
doi:10.1161/JAHA.120.017293
4. Slaughter MS, Badhwar V, Ising M, et al. Optimum surgical treatment
for tricuspid valve infective endocarditis: An analysis of the Society
of Thoracic Surgeons national database. J Thorac Cardiovasc Surg .
2021;161(4):1227-1235.e1. doi:10.1016/j.jtcvs.2019.10.124
5. Luc JGY, Choi JH, Kodia K, et al. Valvectomy versus replacement for
the surgical treatment of infective tricuspid valve endocarditis: a
systematic review and meta-analysis. Ann Cardiothorac Surg .
2019;8(6):610-620. doi:10.21037/acs.2019.11.06
6. Macedo J, Grawe ES. Hypoxemia Requiring Venovenous Extracorporeal
Membrane Oxygenation after Tricuspid Valvulectomy for Infective
Endocarditis. CASE . 2019;3(4):183-186.
doi:10.1016/j.case.2019.04.002
7. Hull SC, Jadbabaie F. When Is Enough Enough? The Dilemma of Valve
Replacement in a Recidivist Intravenous Drug User. Ann Thorac
Surg . 2014;97(5):1486-1487. doi:10.1016/j.athoracsur.2014.02.010
8. Elbatarny M, Bahji A, Bisleri G, Hamilton A. Management of
endocarditis among persons who inject drugs: A narrative review of
surgical and psychiatric approaches and controversies. Gen Hosp
Psychiatry . 2019;57:44-49. doi:10.1016/j.genhosppsych.2019.01.008